Quinn Opportunity Partners LLC Repare Therapeutics Inc. Transaction History
Quinn Opportunity Partners LLC
- $1.08 Billion
- Q2 2025
A detailed history of Quinn Opportunity Partners LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 40,000 shares of RPTX stock, worth $61,600. This represents 0.01% of its overall portfolio holdings.
Number of Shares
40,000Holding current value
$61,600% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RPTX
# of Institutions
53Shares Held
30.2MCall Options Held
50KPut Options Held
900-
Bvf Inc San Francisco, CA10.3MShares$15.9 Million0.45% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$5.3 Million2.59% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$5.12 Million0.1% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.57 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$4.08 Million5.46% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $64.6M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...